Regional Anesthesia in TKA: Impact on Postoperative Joint Motion and Patient Satisfaction

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorKonya City Hospital

About this trial

This is a single-center, prospective, randomized controlled trial aiming to evaluate the effects of different regional anesthesia/analgesia techniques on postoperative knee range of motion (ROM) and patient satisfaction following total knee arthroplasty (TKA). Ninety patients undergoing elective TKA under spinal anesthesia will be randomly assigned to one of three groups: 1) spinal anesthesia with epidural catheter, 2) spinal anesthesia followed by adductor canal catheterization, and 3) spinal anesthesia with multimodal intravenous analgesia. The primary outcome is postoperative knee joint ROM measured on postoperative days 1, 2, and 3. Secondary outcomes include patient satisfaction, Oxford Knee Score, postoperative opioid consumption, and VAS scores. The study is conducted at Konya City Hospital and will be completed over a 6-month period.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Minimum Age: 18 Years

Maximum Age: None

Sex: All

Gender Based: No

Disqualifiers

Skin infection at the planned injection site

Sepsis

Coagulopathy

Refusal of neuraxial anesthesia

Trial design

Design model

Parallel

Treatments tested in this trial

  • Regional anethesia

    Procedure/Surgery

    This single-center, prospective, randomized controlled trial aims to compare the effects of three different postoperative analgesia techniques following spinal anesthesia in patients undergoing total knee arthroplasty (TKA). The study will assess the impact of combined spinal-epidural anesthesia, adductor canal block, and multimodal intravenous analgesia on postoperative knee range of motion (ROM). Secondary outcomes include patient satisfaction, opioid consumption, Oxford Knee Score (OKS), activity levels, and visual analog scale (VAS) pain scores.

Treatment groups

30 Participants
are divided into 3 treatment groups
Group A: Combined Spinal-Epidural AnesthesiaActive comparator 1 intervention
Group B: Adductor Canal BlockActive comparator 1 intervention
Group C: Multimodal Intravenous AnalgesiaSham comparator 1 intervention

Trial outcomes

Primary outcomes

1

Postoperative Knee Range of Motion (ROM)

Knee joint flexion and extension range of motion will be measured using a standard goniometer by a blinded assessor. Measurements will be performed with the patient in a supine position, ensuring standardized positioning for all participants.

Time frame
Postoperative day 1, day 3, day 7, and day 90 after surgery.

Secondary outcomes

1

Total Opioid Consumption

Cumulative opioid consumption (intravenous and oral) will be recorded and converted to morphine milligram equivalents (MME).

Time frame
From the end of surgery to 72 hours postoperatively.
2

Oxford Knee Score (OKS)

Oxford Knee Score (OKS) questionnaire: Functional outcome will be evaluated using the Oxford Knee Score, a validated 12-item questionnaire assessing pain and physical function.To assess knee pain and functional ability from the patient's perspective. Number of questions: 12 Score range: 0 to 48 Interpretation: 0 points = worst possible outcome (severe pain and poor function) 48 points = best possible outcome (no pain and full function) Direction: Higher scores indicate better outcomes

Time frame
Preoperatively (baseline) and postoperative day 90.
3

Visual Analog Scale (VAS) Pain Score

Pain intensity at rest and during movement will be assessed using a 10-cm visual analog scale (0 = no pain, 10 = worst possible pain).

Time frame
Postoperative day 1, day 3, and day 7 after surgery.
4

Incidence of Adverse Events Related to Anesthesia or Analgesia

The occurrence of anesthesia- or analgesia-related complications (e.g., motor weakness, sensory deficits, infection at catheter site, nausea/vomiting, hypotension) will be recorded.

Time frame
Intraoperative period and up to 90 days postoperatively.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.